Galectin Therapeutics Inc.
DE ˙ DB ˙ US3632252025
1,88 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:PHPN / Galectin Therapeutics Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership184,737 shares
Latest Disclosed Value $ 515,416
Goldman Sachs Group Inc ownership in PHPN / Galectin Therapeutics Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 184,737 shares of Galectin Therapeutics Inc. (DE:PHPN) valued at $413,811 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 307,229 shares of Galectin Therapeutics Inc.. This represents a change in shares of -39.87% during the quarter. The current value of the position is $347,306 USD.

Goldman Sachs Group Inc has a history of taking positions in derivatives of the underlying security (PHPN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:PHPN / Galectin Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 184,737 -122,492 -39.87 515 -59.70 0.0000
2026-02-10 2025-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 307,229 285,215 1,295.61 1,278 1,274.19 0.0002
2025-11-14 2025-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 22,014 -4,255 -16.20 93 69.09 0.0000
2025-08-14 2025-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 26,269 15,570 145.53 55 323.08 0.0000
2025-06-27 2025-03-31 13F/A-2 GALECTIN THERAPEUTICS CMN 363225202 10,699 -36,822 -77.49 13 -78.69 0.0000
2025-05-16 2025-03-31 13F/A-1 GALECTIN THERAPEUTICS CMN 363225202 10,699 -36,822 13 0.0000
2025-05-09 2025-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 10,699 -36,822 13 0.0000
2025-02-11 2024-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 47,521 14,489 43.86 61 -32.22 0.0000
2024-11-14 2024-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 33,032 10,469 46.40 91 80.00 0.0000
2024-08-13 2024-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 22,563 22,563 51 0.0000
2024-05-14 2022-09-30 13F/A-1 GALECTIN THERAPEUTICS CMN 363225202 0 -18,419 -100.00 0 0.0000
2024-05-14 2022-09-30 13F/A-1 GALECTIN THERAPEUTICS CMN 363225202 0 0
2022-11-10 2022-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 0 -18,419 0 0.0000
2024-05-14 2022-06-30 13F/A-2 GALECTIN THERAPEUTICS CMN 363225202 18,419 7,659 71.18 0 -100.00 0.0000
2022-08-18 2022-06-30 13F/A-1 GALECTIN THERAPEUTICS CMN 363225202 18,419 7,659 24 0.0000
2022-08-15 2022-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 18,419 7,659 24 0.0000
2022-05-16 2022-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 10,760 -531 -4.70 17 -26.09 0.0000
2022-02-17 2021-12-31 13F/A-1 GALECTIN THERAPEUTICS CMN 363225202 11,291 -3,426 -23.28 23 -59.65 0.0000
2022-02-14 2021-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 11,291 -3,426 23 0.0000
2022-01-20 2021-09-30 13F/A-1 GALECTIN THERAPEUTICS CMN 363225202 14,717 -3,458 -19.03 57 -1.72 0.0000
2021-11-10 2021-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 14,717 -3,458 57 0.0000
2021-08-13 2021-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 18,175 -2,637 -12.67 58 28.89 0.0000
2021-05-17 2021-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 20,812 -2,349 -10.14 45 -13.46 0.0000
2021-02-12 2020-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 23,161 2,507 12.14 52 -5.45 0.0000
2020-11-13 2020-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 20,654 -140 -0.67 55 -14.06 0.0000
2020-08-12 2020-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 20,794 4,119 24.70 64 93.94 0.0000
2020-05-15 2020-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 16,675 -15,401 -48.01 33 -64.13 0.0000
2020-02-14 2019-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 32,076 -9,516 -22.88 92 -39.47 0.0000
2019-11-14 2019-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 41,592 41,592 152 0.0000
2019-08-14 2019-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 0 -174,391 -100.00 0 -100.00
2019-05-15 2019-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 174,391 160,323 1,139.63 891 1,756.25 0.0003
2019-02-14 2018-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 14,068 -1,888 -11.83 48 -50.00 0.0000
2018-11-14 2018-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 15,956 15,956 96 0.0000
2018-05-15 2018-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 0 -12,528 -100.00 0 -100.00
2018-02-14 2017-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 12,528 -1,521 -10.83 42 40.00 0.0000
2017-11-14 2017-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 14,049 -3,055 -17.86 30 -28.57 0.0000
2017-08-14 2017-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 17,104 -267 -1.54 42 5.00 0.0000
2017-05-18 2017-03-31 13F/A-1 GALECTIN THERAPEUTICS CMN 363225202 17,371 2,026 13.20 40 166.67 0.0000
2017-05-15 2017-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 17,371 40
2017-02-14 2016-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 15,345 174 1.15 15 -11.76 0.0000
2016-11-14 2016-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 15,171 -67 -0.44 17 -22.73 0.0000
2016-08-15 2016-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 15,238 -1,043 -6.41 22 -4.35 0.0000
2016-05-13 2016-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 16,281 -7,664 -32.01 23 -41.03 0.0000
2016-02-16 2015-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 23,945 -18,987 -44.23 39 -61.00 0.0000
2015-11-13 2015-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 42,932 -2,580 -5.67 100 -19.35 0.0000
2015-08-14 2015-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 45,512 26,476 139.08 124 93.75 0.0000
2015-05-15 2015-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 19,036 4,996 35.58 64 30.61 0.0000
2015-02-13 2014-12-31 13F GALECTIN THERAPEUTICS CMN 363225202 14,040 2,999 27.16 49 -12.50 0.0000
2014-11-14 2014-09-30 13F GALECTIN THERAPEUTICS CMN 363225202 11,041 -30,869 -73.66 56 -90.33 0.0000
2014-08-14 2014-06-30 13F GALECTIN THERAPEUTICS CMN 363225202 41,910 36,766 714.74 579 632.91 0.0002
2014-05-15 2014-03-31 13F GALECTIN THERAPEUTICS CMN 363225202 5,144 5,144 79 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-02-14 2016-12-31 13F GALECTIN THERAPEUTICS CMN Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-14 2016-09-30 13F GALECTIN THERAPEUTICS CMN Call 1,200 0.00 1 -50.00 n/a n/a n/a
2016-08-15 2016-06-30 13F GALECTIN THERAPEUTICS CMN Call 1,200 -99.76 2 -99.72 n/a n/a n/a
2016-05-13 2016-03-31 13F GALECTIN THERAPEUTICS CMN Call 499,300 0.00 714 -12.82 n/a n/a n/a
2016-02-16 2015-12-31 13F GALECTIN THERAPEUTICS CMN Call 499,300 27,638.89 819 20,375.00 n/a n/a n/a
2015-11-13 2015-09-30 13F GALECTIN THERAPEUTICS CMN Call 1,800 50.00 4 33.33 n/a n/a n/a
2015-08-14 2015-06-30 13F GALECTIN THERAPEUTICS CMN Call 1,200 -50.00 3 -62.50 n/a n/a n/a
2015-05-15 2015-03-31 13F GALECTIN THERAPEUTICS CMN Call 2,400 -33.33 8 -33.33 n/a n/a n/a
2015-02-13 2014-12-31 13F GALECTIN THERAPEUTICS CMN Call 3,600 -40.98 12 -61.29 n/a n/a n/a
2014-11-14 2014-09-30 13F GALECTIN THERAPEUTICS CMN Call 6,100 -65.54 31 -87.30 n/a n/a n/a
2014-08-14 2014-06-30 13F GALECTIN THERAPEUTICS CMN Call 17,700 -53.30 244 -57.93 n/a n/a n/a
2014-05-15 2014-03-31 13F GALECTIN THERAPEUTICS CMN Call 37,900 580 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-08-15 2016-06-30 13F GALECTIN THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-13 2016-03-31 13F GALECTIN THERAPEUTICS CMN Put 4,800 7 n/a n/a n/a
2015-11-13 2015-09-30 13F GALECTIN THERAPEUTICS CMN Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F GALECTIN THERAPEUTICS CMN Put 2,100 -27.59 6 -40.00 n/a n/a n/a
2015-05-15 2015-03-31 13F GALECTIN THERAPEUTICS CMN Put 2,900 -59.15 10 -60.00 n/a n/a n/a
2015-02-13 2014-12-31 13F GALECTIN THERAPEUTICS CMN Put 7,100 -21.11 25 -44.44 n/a n/a n/a
2014-11-14 2014-09-30 13F GALECTIN THERAPEUTICS CMN Put 9,000 -8.16 45 -66.67 n/a n/a n/a
2014-08-14 2014-06-30 13F GALECTIN THERAPEUTICS CMN Put 9,800 -2.97 135 -12.90 n/a n/a n/a
2014-05-15 2014-03-31 13F GALECTIN THERAPEUTICS CMN Put 10,100 155 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.